Medicare Enrolled

Dr. Jorge Figueroa Flores, M.D.

Endocrinology · Abilene, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
5302 BUFFALO GAP RD STE 104, Abilene, TX 79606
3253076226
In practice since 2009 (16 years)
NPI: 1548499098 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Figueroa Flores from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Figueroa Flores? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Figueroa Flores

Dr. Jorge Figueroa Flores is an endocrinology in Abilene, TX, with 16 years in practice. Based on federal Medicare data, Dr. Figueroa Flores performed 1,252 Medicare services across 530 unique beneficiaries.

Between the years covered by Open Payments, Dr. Figueroa Flores received a total of $4,100 from 14 pharmaceutical and/or device companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Figueroa Flores is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years in practice▲ Top 33% volume in TX$ $4,100 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,252
Medicare services
Top 33% in TX for endocrinology
530
Unique beneficiaries
$70
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~78 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Hospital follow-up visit, moderate complexity544$60$226
Office visit, established patient (30-39 min)340$85$364
Hospital follow-up visit, low complexity112$38$142
New patient office visit (45-59 min)77$115$481
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report55$23$101
Initial hospital admission, high complexity53$115$511
Office visit, established patient (20-29 min)30$55$257
Office visit, established patient, complex (40-54 min)21$111$510
Hospital follow-up visit, high complexity20$89$340
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$4,100
Total received (2018-2024)
Avg $586/year across 7 years
Top 47% in TX for endocrinology
14
Companies
356
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,100 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$463
2023
$650
2022
$404
2021
$652
2020
$407
2019
$760
2018
$765

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$3,234
Insulet Corporation
$226
Abbott Laboratories
$144
Amgen Inc.
$106
Boehringer Ingelheim Pharmaceuticals, Inc.
$100
Tandem Diabetes Care, Inc.
$86
Mannkind Corporation
$59
SANOFI-AVENTIS U.S. LLC
$33
AstraZeneca Pharmaceuticals LP
$29
CVRx, Inc.
$22
Medtronic, Inc.
$19
Corcept Therapeutics
$18
Lilly USA, LLC
$13
Merck Sharp & Dohme Corporation
$11
Top 3 companies account for 87.9% of total payments
Associated products mentioned in payments ›
AFREZZA · Barostim Neo System · FARXIGA · FREESTYLE LIBRE 3 · HUMULIN · JANUVIA · JARDIANCE · Korlym · LANTUS · MINIMED 780G · Omnipod · Ozempic · RYBELSUS · Repatha · Rybelsus · Saxenda · TOUJEO · Tresiba · Victoza · Wegovy · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $327 per 100 Medicare services performed
Looking for a endocrinology in Abilene?
Compare endocrinologys in the Abilene area by procedure volume, costs, and industry payment transparency.
Browse endocrinologys nearby

Geographic Context

Endocrinologys within 10 mi
4
Per 100K population
2.8
County median income
$66,406
Nearest hospital
OCEANS BEHAVIORAL HOSPITAL OF ABILENE
8.9 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Figueroa Flores is a clinical cardiology specialist, with moderate Medicare volume, and low-engagement industry engagement, with 16 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Figueroa Flores experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Figueroa Flores performed 544 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Figueroa Flores receive payments from pharmaceutical companies?
Yes. Dr. Figueroa Flores received a total of $4,100 from 14 companies across 356 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Figueroa Flores's costs compare to other endocrinologys in Abilene?
Dr. Figueroa Flores's average Medicare payment per service is $70. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Figueroa Flores) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →